Meningitis vaccines are used to prevent infection caused by Neisseria meningitidis. Meningitis is a rare infection that affects the delicate membranes that surround the brain and spinal cord, known as meninges. Meningococcal meningitis is a type of bacterial meningitis caused by the bacterium Neisseria meningitidis. Meningitis can be caused by bacteria, viruses, fungus, and/or non-infectious illnesses. Meningitis is an inflammation (swelling) of the protective membranes covering the brain and spinal cord. It is a rare infection that affects the delicate membranes that cover the brain and spinal cord. Viral infections are the most common cause of meningitis, followed by bacterial infections and, rarely, fungal and parasitic infections.
Global Meningitis Vaccines Market is estimated to be valued at US$ 4,070.1 million in 2022 and is expected to exhibit a CAGR of 6.4% during the forecast period (2022-2030). Different meningitis versions are effective against some or all types of meningococcus: A, B, C, W-135, and Y. these vaccines are between 85 and 100% effective for at least two years. If worried about getting Meningitis, it's important to get vaccinated. Meningitis is a condition that can be very serious and can lead to paralysis. The good news is that one can avoid the problem by getting vaccinated. People can get vaccinated against the disease with Meningitis vaccines designed for this purpose. The vaccine will protect against the disease for two years. There are many benefits of meningitis vaccine, but there are also some potential risks involved. Though meningitis is not contagious, it is a life-threatening. The vaccine prevents the infection, which can be life-threatening and even fatal. That's why it's important to get people vaccinated as soon as possible, especially if they are teenagers. The bacteria that cause meningitis can spread when people infected with meningitis cough and/or sneeze. Meningococcal meningitis is a type of bacterial meningitis caused by the bacterium Neisseria meningitidis. Bacterial meningitis can occur at any age. Infants are at a larger risk of developing bacterial meningitis. All children age 11 & 12 years should receive meningococcal vaccine (MenACWY) and a booster dose at age 16 years. Vaccine is also recommended for all adolescents’ ages 13 through 18 years who did not receive a dose at age 11-12 years. Teens and young adults (16 through 23 years old) also may get a MenB vaccine. The Centers for Disease Control and Prevention (CDC) recommends meningococcal vaccination for other children and adults who are at increased risk for the disease. For children under the age of 7 years, administer a booster dose 3 years after completion of the primary series and every 5 years thereafter. For children 7 years old or older and adults, administer a booster dose 5 years after completion of the primary series and every 5 years thereafter. Meningitis vaccine is highly effective against four strains of the bacteria. Three strains are common in the U.S. and fourth strain protects travelers to certain countries where the disease is more common. The CDC first recommended preteens and teens get a MenACWY vaccine in 2005. Since then, rates of meningococcal disease in teens caused by serogroups C, Y, and W have decreased by over 90% (serogroup A meningococcal disease continues to be very rare in the United States). However, not all causes of meningitis and septicemia are vaccine preventable so being able to recognize the symptoms is important.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
November 2023
Categories |